7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Albuminuria D000419 18 associated lipids
Adrenal Hyperplasia, Congenital D000312 2 associated lipids
Adenocarcinoma D000230 166 associated lipids
Addison Disease D000224 3 associated lipids
Actinomycosis D000196 2 associated lipids
Actinobacillus Infections D000189 4 associated lipids
Acromegaly D000172 6 associated lipids
Vestibulocochlear Nerve Diseases D000160 1 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Tang ZL et al. An experimental study addressing the promotion of mandibular defect repair through the intermittent subcutaneous injection of parathyroid hormone. 2014 J. Oral Maxillofac. Surg. pmid:24071373
Nakashima T [Coupling and communication between bone cells]. 2014 Clin Calcium pmid:24870836
Shimamura M et al. OPG/RANKL/RANK axis is a critical inflammatory signaling system in ischemic brain in mice. 2014 Proc. Natl. Acad. Sci. U.S.A. pmid:24847069
Davaine JM et al. Osteoprotegerin, pericytes and bone-like vascular calcification are associated with carotid plaque stability. 2014 PLoS ONE pmid:25259713
Chaganti RK et al. Elevation of serum tumor necrosis factor α in patients with periprosthetic osteolysis: a case-control study. 2014 Clin. Orthop. Relat. Res. pmid:24307062
Fuernau G et al. Growth-differentiation factor 15 and osteoprotegerin in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the IABP-SHOCK II-trial. 2014 Eur. J. Heart Fail. pmid:24903195
Huang JW et al. Osteoprotegerin, inflammation and dyslipidemia are associated with abdominal aortic calcification in non-diabetic patients on peritoneal dialysis. 2014 Nutr Metab Cardiovasc Dis pmid:24361071
Kinney JS et al. Crevicular fluid biomarkers and periodontal disease progression. 2014 J. Clin. Periodontol. pmid:24303954
Marques EA et al. Response of bone mineral density, inflammatory cytokines, and biochemical bone markers to a 32-week combined loading exercise programme in older men and women. 2013 Sep-Oct Arch Gerontol Geriatr pmid:23623588
Liu S et al. Association between g.19163A>G and g.23298T>C genetic variants of the osteoprotegerin gene and bone mineral density in Chinese women. 2013 Oct-Dec Hormones (Athens) pmid:24457406
Chiang PH et al. Zoledronic acid treatment for cancerous bone metastases: a phase IV study in Taiwan. 2013 Oct-Dec J Cancer Res Ther pmid:24518712
Canto-Cetina T et al. Polymorphism of LRP5, but not of TNFRSF11B, is associated with a decrease in bone mineral density in postmenopausal Maya-Mestizo women. 2013 Nov-Dec Am. J. Hum. Biol. pmid:24130145
Horshuns'ka MIu et al. [Biological role of fetuin A and its potential importance for prediction of cardiovascular risk in patients with type 2 diabetes mellitus]. 2013 May-Jun Ukr Biokhim Zh (1999) pmid:23937044
Zamora PO et al. Biocompatibility and inflammation profile of B2A-coated granules used in arthrodesis. 2013 Mar-Apr Int. J. Toxicol. pmid:23422080
Esteghamati A et al. Comparison of osteoprotegerin and vascular endothelial growth factor in normoalbuminuric Type 1 diabetic and control subjects. 2013 Jul-Aug J. Endocrinol. Invest. pmid:23877020
Glintborg D et al. Plasma osteoprotegerin is associated with testosterone levels but unaffected by pioglitazone treatment in patients with polycystic ovary syndrome. 2013 Jul-Aug J. Endocrinol. Invest. pmid:23211475
Nanjundaiah SM et al. Kinetics and interplay of mediators of inflammation-induced bone damage in the course of adjuvant arthritis. 2013 Jan-Mar Int J Immunopathol Pharmacol pmid:23527707
Guzel S et al. Osteoprotegerin, leptin and IL-6: association with silent myocardial ischemia in type 2 diabetes mellitus. 2013 Diab Vasc Dis Res pmid:22496403
Tao H et al. OPG/RANK/RANKL axis as a potential therapeutic target for atrial fibrillation. 2013 Cardiology pmid:23751957
Xi L et al. OPG/RANK/RANKL axis in atrial fibrillation. 2013 Cardiology pmid:23752030
Ostrowska Z et al. Assessment of the relationship between melatonin, hormones of the pituitary-ovarian, -thyroid and -adrenocortical axes, and osteoprotegerin and its ligand sRANKL in girls with anorexia nervosa. 2013 Postepy Hig Med Dosw (Online) pmid:23752595
Uehara H et al. Induction of retinol-binding protein 4 and placenta-specific 8 expression in human prostate cancer cells remaining in bone following osteolytic tumor growth inhibition by osteoprotegerin. 2013 Int. J. Oncol. pmid:23708710
Luo J et al. 1,25-dihydroxyvitamin D3 inhibits the RANKL pathway and impacts on the production of pathway-associated cytokines in early rheumatoid arthritis. 2013 Biomed Res Int pmid:23710436
Zhu Y et al. Deciduous dental pulp stem cells are involved in osteoclastogenesis during physiologic root resorption. 2013 J. Cell. Physiol. pmid:22674471
Neunaber C et al. Differentiation of osteoprogenitor cells is affected by trauma-haemorrhage. 2013 Injury pmid:23773407
Hakimi M et al. The expression of glycophorin A and osteoprotegerin is locally increased in carotid atherosclerotic lesions of symptomatic compared to asymptomatic patients. 2013 Int. J. Mol. Med. pmid:23722820
Van Schepdael A et al. A mechanobiological model of orthodontic tooth movement. 2013 Biomech Model Mechanobiol pmid:22539046
Pacifici R Osteoimmunology and its implications for transplantation. 2013 Am. J. Transplant. pmid:23915249
Albu A et al. Bone metabolism regulators and arterial stiffness in postmenopausal women. 2013 Maturitas pmid:23916080
Bauer S et al. Early detection of bone metabolism changes under different antiepileptic drugs (ED-BoM-AED)--a prospective multicenter study. 2013 Epilepsy Res. pmid:23916144
Nile CJ et al. Comparison of circulating tumour necrosis factor superfamily cytokines in periodontitis patients undergoing supportive therapy: a case-controlled cross-sectional study comparing smokers and non-smokers in health and disease. 2013 J. Clin. Periodontol. pmid:23919740
Kim HR et al. The ratio of osteoprotegerin to fetuin-a is independently associated with vascular stiffness in hemodialysis patients. 2013 Nephron Clin Pract pmid:23921088
O'Sullivan EP et al. A comparison of osteoprotegerin with adiponectin and high-sensitivity C-reactive protein (hsCRP) as a marker for insulin resistance. 2013 Metab. Clin. Exp. pmid:22841521
Steensma MR et al. Targeting the giant cell tumor stromal cell: functional characterization and a novel therapeutic strategy. 2013 PLoS ONE pmid:23922683
Czyzewska-Buczyńska A et al. [Assessment of osteopontin and osteoprotegerin levels in abdominal aortic aneurysm patients]. 2013 Prz. Lek. pmid:24003660
Fathilah SN et al. Labisia pumila regulates bone-related genes expressions in postmenopausal osteoporosis model. 2013 BMC Complement Altern Med pmid:24007208
Einvik G et al. Novel cardiovascular risk markers in depression: no association between depressive symptoms and osteoprotegerin or adiponectin in persons at high risk for sleep apnea. 2013 J Affect Disord pmid:22862888
Mozzati M et al. Oral mucosa produces cytokines and factors influencing osteoclast activity and endothelial cell proliferation, in patients with osteonecrosis of jaw after treatment with zoledronic acid. 2013 Clin Oral Investig pmid:22864527
Benito-Martin A et al. Osteoprotegerin in exosome-like vesicles from human cultured tubular cells and urine. 2013 PLoS ONE pmid:24058411
Lau CP et al. Comparison of the anti-tumor effects of denosumab and zoledronic acid on the neoplastic stromal cells of giant cell tumor of bone. 2013 Connect. Tissue Res. pmid:24060052
Corrado A et al. RANKL/OPG ratio and DKK-1 expression in primary osteoblastic cultures from osteoarthritic and osteoporotic subjects. 2013 J. Rheumatol. pmid:23457386
Koluman BU et al. Association between osteoprotegerin, fetuin-A, carotid intima media thickness, and urinary albumin excretion in Type 2 diabetes. 2013 Clin. Nephrol. pmid:23458176
Wang J et al. Inhibitory effect of metformin on bone metastasis of cancer via OPG/RANKL/RANK system. 2013 Med. Hypotheses pmid:24074896
Kuo PL et al. MicroRNA-33a functions as a bone metastasis suppressor in lung cancer by targeting parathyroid hormone related protein. 2013 Biochim. Biophys. Acta pmid:23458685
Li F et al. Effect of parathyroid hormone on experimental tooth movement in rats. 2013 Am J Orthod Dentofacial Orthop pmid:24075660
Sato K et al. RANKL synthesized by both stromal cells and cancer cells plays a crucial role in osteoclastic bone resorption induced by oral cancer. 2013 Am. J. Pathol. pmid:23499553
Pneumaticos SG et al. Osteoprotegerin expression during the micro- and macrometastatic phases of the osteoblastic metastasis in prostate cancer: therapeutic implications. 2013 Expert Opin. Ther. Targets pmid:24024908
Sooampon S et al. Transient receptor potential vanilloid-1 regulates osteoprotegerin/RANKL homeostasis in human periodontal ligament cells. 2013 J. Periodont. Res. pmid:22587561
Matuszewski Ł et al. Effect of implanted bisphosphonate-enriched cement on the trabecular microarchitecture of bone in a rat model using micro-computed tomography. 2013 Int Orthop pmid:23503639
Tarantino U et al. A new antiresorptive approach to the treatment of fragility fractures: long-term efficacy and safety of denosumab. 2013 Aging Clin Exp Res pmid:24046047
Galli C et al. GSK3b-inhibitor lithium chloride enhances activation of Wnt canonical signaling and osteoblast differentiation on hydrophilic titanium surfaces. 2013 Clin Oral Implants Res pmid:22626030
Albers J et al. Canonical Wnt signaling inhibits osteoclastogenesis independent of osteoprotegerin. 2013 J. Cell Biol. pmid:23401003
Nahidi L et al. Osteoprotegerin exerts its pro-inflammatory effects through nuclear factor-κB activation. 2013 Dig. Dis. Sci. pmid:24048682
Hope S et al. Interleukin 1 receptor antagonist and soluble tumor necrosis factor receptor 1 are associated with general severity and psychotic symptoms in schizophrenia and bipolar disorder. 2013 Schizophr. Res. pmid:23403415
D'Amico L et al. Bone metastases in gastric cancer follow a RANKL-independent mechanism. 2013 Oncol. Rep. pmid:23404437
Mogi M and Kondo A The presence of RANKL-OPG complex in human osteosarcoma U2OS. 2013 J Immunoassay Immunochem pmid:23859786
Zappitelli T et al. The G60S connexin 43 mutation activates the osteoblast lineage and results in a resorption-stimulating bone matrix and abrogation of old-age-related bone loss. 2013 J. Bone Miner. Res. pmid:23606335
Kao SY et al. Loss of osteoprotegerin expression in the inner ear causes degeneration of the cochlear nerve and sensorineural hearing loss. 2013 Neurobiol. Dis. pmid:23607938
Wu M et al. Vascular calcification: an update on mechanisms and challenges in treatment. 2013 Calcif. Tissue Int. pmid:23456027
Venojärvi M et al. 12 weeks' aerobic and resistance training without dietary intervention did not influence oxidative stress but aerobic training decreased atherogenic index in middle-aged men with impaired glucose regulation. 2013 Food Chem. Toxicol. pmid:23623841
Kitamura K et al. Zebrafish scales respond differently to in vitro dynamic and static acceleration: analysis of interaction between osteoblasts and osteoclasts. 2013 Comp. Biochem. Physiol., Part A Mol. Integr. Physiol. pmid:23632157
Shen L et al. Association between osteoprotegerin genetic variants and bone mineral density in Chinese women. 2013 Int. Immunopharmacol. pmid:23619553
Xie GQ et al. Relationship between serum TGF-β1, OPG levels and osteoporotic risk in native Chinese women. 2013 Clin. Chim. Acta pmid:23643930
Ding CZ et al. [Effects of zhengqing fengtongning tablet and methotrexate on the serum OPG/RANKL and IL-17 of collagen-induced arthritis rats]. 2013 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:23646485
Brabnikova Maresova K et al. Acute effects of glucocorticoids on serum markers of osteoclasts, osteoblasts, and osteocytes. 2013 Calcif. Tissue Int. pmid:23247536
Eren MA et al. Association of parity with osteoprotegerin levels and atherosclerosis. 2013 Arch. Gynecol. Obstet. pmid:23287888
Kim SJ et al. Compressive stress induced the up-regulation of M-CSF, RANKL, TNF-α expression and the down-regulation of OPG expression in PDL cells via the integrin-FAK pathway. 2013 Arch. Oral Biol. pmid:23219295
Kanzaki H et al. Mutations in K-Ras linked to levels of osteoprotegerin and sensitivity to TRAIL-induced cell death in pancreatic ductal adenocarcinoma cells. 2013 Exp. Mol. Pathol. pmid:23219833
Kim J et al. Lipoproteins are an important bacterial component responsible for bone destruction through the induction of osteoclast differentiation and activation. 2013 J. Bone Miner. Res. pmid:23633269
Wang H et al. Combination gene therapy targeting on interleukin-1β and RANKL for wear debris-induced aseptic loosening. 2013 Gene Ther. pmid:22318091
Hussien YM et al. Polymorphism in vitamin D receptor and osteoprotegerin genes in Egyptian rheumatoid arthritis patients with and without osteoporosis. 2013 Mol. Biol. Rep. pmid:23271131
Kuang B et al. Combined degenerative and regenerative remodeling responses of the mandibular condyle to experimentally induced disordered occlusion. 2013 Am J Orthod Dentofacial Orthop pmid:23273362
Flórez-Moreno GA et al. Time-related changes in salivary levels of the osteotropic factors sRANKL and OPG through orthodontic tooth movement. 2013 Am J Orthod Dentofacial Orthop pmid:23273364
Ko GJ A biomarker, osteoprotegerin, in patients undergoing hemodialysis. 2013 Korean J. Intern. Med. pmid:24307839
Lee JE et al. Serum osteoprotegerin is associated with vascular stiffness and the onset of new cardiovascular events in hemodialysis patients. 2013 Korean J. Intern. Med. pmid:24307842
Naidu VG et al. RANKL targeted peptides inhibit osteoclastogenesis and attenuate adjuvant induced arthritis by inhibiting NF-κB activation and down regulating inflammatory cytokines. 2013 Chem. Biol. Interact. pmid:23333834
Zhang Q et al. Local gene transfer of OPG prevents joint damage and disease progression in collagen-induced arthritis. 2013 ScientificWorldJournal pmid:24222748
Yao Y et al. Combination of MTX and LEF attenuates inflammatory bone erosion by down-regulation of receptor activator of NF-kB ligand and interleukin-17 in type II collagen-induced arthritis rats. 2013 Rheumatol. Int. pmid:23334376
Luo ZR et al. [A study of relationship between dialectical classification according to traditional Chinese medicine of acute coronary syndrome with serum osteoprotegerin and its ligand]. 2013 Zhonghua Wei Zhong Bing Ji Jiu Yi Xue pmid:24225213
Zhang F et al. Association analyses of osteoprotegerin gene polymorphisms with bone mineral density in Chinese postmenopausal women. 2013 Med. Oncol. pmid:23335067
Tisato V et al. GM-CSF exhibits anti-inflammatory activity on endothelial cells derived from chronic venous disease patients. 2013 Mediators Inflamm. pmid:24327798
Su SJ et al. Caffeine regulates osteogenic differentiation and mineralization of primary adipose-derived stem cells and a bone marrow stromal cell line. 2013 Int J Food Sci Nutr pmid:23301724
Aoki A et al. Association of serum osteoprotegerin with vascular calcification in patients with type 2 diabetes. 2013 Cardiovasc Diabetol pmid:23302066
Pathan E et al. Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in ankylosing spondylitis. 2013 Ann. Rheum. Dis. pmid:22984171
Wong KC et al. Drynaria fortunei-derived total flavonoid fraction and isolated compounds exert oestrogen-like protective effects in bone. 2013 Br. J. Nutr. pmid:23302510
Wada T [RANKL inhibition in bone metastases]. 2013 Nippon Yakurigaku Zasshi pmid:23302944
Guerra-Menéndez L et al. IGF-I increases markers of osteoblastic activity and reduces bone resorption via osteoprotegerin and RANK-ligand. 2013 J Transl Med pmid:24161214
Romagnoli C et al. Role of GSH/GSSG redox couple in osteogenic activity and osteoclastogenic markers of human osteoblast-like SaOS-2 cells. 2013 FEBS J. pmid:23176170
Revu S et al. Synovial membrane immunohistology in early-untreated rheumatoid arthritis reveals high expression of catabolic bone markers that is modulated by methotrexate. 2013 Arthritis Res. Ther. pmid:24295447
Kadkhodazadeh M et al. Analysis of RANKL gene polymorphism (rs9533156 and rs2277438) in Iranian patients with chronic periodontitis and periimplantitis. 2013 Arch. Oral Biol. pmid:23177932
Gutiérrez-Rojas I et al. Amylin exerts osteogenic actions with different efficacy depending on the diabetic status. 2013 Mol. Cell. Endocrinol. pmid:23178165
Barbieri G et al. Biochemical markers of bone metabolism in gingival crevicular fluid during early orthodontic tooth movement. 2013 Angle Orthod pmid:22716279
Bolzoni M et al. Immunomodulatory drugs lenalidomide and pomalidomide inhibit multiple myeloma-induced osteoclast formation and the RANKL/OPG ratio in the myeloma microenvironment targeting the expression of adhesion molecules. 2013 Exp. Hematol. pmid:23178378
Lee MH et al. The effect of surface microgrooves and anodic oxidation on the surface characteristics of titanium and the osteogenic activity of human periodontal ligament cells. 2013 Arch. Oral Biol. pmid:22717323
Dalcico R et al. Protective mechanisms of simvastatin in experimental periodontal disease. 2013 J. Periodontol. pmid:23181416
Balani D et al. Interleukin-17A stimulates granulocyte-macrophage colony-stimulating factor release by murine osteoblasts in the presence of 1,25-dihydroxyvitamin D(3) and inhibits murine osteoclast development in vitro. 2013 Arthritis Rheum. pmid:23124514
Mercatali L et al. RANK/RANK-L/OPG in patients with bone metastases treated with anticancer agents and zoledronic acid: a prospective study. 2013 Int J Mol Sci pmid:23702841
Braun T et al. Mitogen-activated protein kinase 2 regulates physiological and pathological bone turnover. 2013 J. Bone Miner. Res. pmid:23169443
Rivadeneira F Hunting osteoporosis susceptibility genes: bigger is better but diverse is also welcome. 2013 Endocrine pmid:23001603
Scott JP et al. Effect of recovery duration between two bouts of running on bone metabolism. 2013 Med Sci Sports Exerc pmid:23034642

Table of Content